Customer Services: +44 (0) 114 345 0000 | Reception: +44 (0) 114 345 3200

Company News

JRI on tour in China

21st November 2017
'JRI Orthopaedics China



Award winning British healthcare company JRI Orthopaedics continues to strengthened its foothold in China with a surgeon instructional tour. JRI Orthopaedics along with its partner in China AK Medical,  invited surgeon Mr Kerry Acton to demonstrate his surgical approach and use off JRI’s Furlong Evolution femoral stem and CSF Plus acetabular cup to surgeons in China.

Mr Acton,Royal Surrey Hospital, Guildford, Surrey, performed live surgery which was simultaneously also screened live, via a video link to another 30 surgeons watching in adjacent rooms. In fact he visited four cities in as many days, Harbin, Dalian, Guiyang concluding with a keynote presentation at a major orthopaedic meeting in Beijing.

Mr Acton also hit our news feed a couple of years back for the successful implantation of an Evolution hip prosthesis into a Triathlete Micheal Rix

Last year, the company secured a major £4m sub-manufacturing contract with China’s largest domestic orthopaedic producer, AK Medical. The three-year deal means Chinese designed hip implants are being manufactured in JRI’s state-of-the-art Sheffield plant for sale in China.

JRI Orthopaedics, which employs 115 people, is the largest UK-based orthopaedic manufacturer. It has world-class expertise in the design, development and manufacture of orthopaedic implants and surgical instruments. The multi-award winning company was the first in the world to develop a Hydroxyapatite ceramic coating on hip replacements – a synthetic version of the natural mineral present in bones. By perfecting this coating process, JRI developed the Furlong cementless implant that bonds biologically with the patient’s own bone, providing for long-term secure fixation and the possibility of a hip for life.

Uniquely, JRI is wholly owned by the charity Orthopaedic Research UK (ORUK) and has donated £12m over the last 10 years to fund world class research into bone and joint disease at centres of excellence across the country.

Go back